TCL Archive “Exciting” Developments In Diagnosis, Screening Methods Reported By Berlin As He Leaves NCI Post April 11, 1975
TCL Archive In Brief: Terry To Leave NCI for Job As VP Of Revlon Health Care Group; NCI Tracking Source Of Breakthroughs June 18, 1982
TCL Archive NHLBI Advisers Commit Funding TO NCI’s Women’s Health Trials, Tamoxifen Trial March 8, 1991
TCL Archive Adverse data from cancer prevention trial makes Merck withdraw Vioxx from market. Researchers discuss implications for other cancer prevention trials. October 15, 2004
